Deoxycholic Acid comment watch save
GeriatricPediatric

  • TRADE NAME: Kybella (Kythera)
  • INDICATIONS: Improvement in the appearance of moderate to severe convexity or fullness associated with submental fat
  • CLASS: Cytolytic
  • HALF-LIFE: N/A
  • FDA APPROVAL DATE: 04/29/2015
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    None known

Contra-indicated in the presence of infection at the injection sites.

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top